Admission Date:  [**2103-8-26**]              Discharge Date:   [**2103-10-11**]

Date of Birth:  [**2054-6-24**]             Sex:   M

Service: MEDICINE

Allergies:
No Known Allergies / Adverse Drug Reactions

Attending:[**First Name3 (LF) 3913**]
Chief Complaint:
Epistaxis and petechiae on lower extremities

Major Surgical or Invasive Procedure:
s/p splenectomy

History of Present Illness:
49 y/o male with HIV/AIDS, CD4 8, on ART, and diagnosed with
DLBCL in [**2103-6-13**], was just discharged home after a lengthy
hospitalization during which his lymphoma was diagnosed, and he
was started on [**Hospital1 **], received 2 cycles of chemotherapy,
finished 2nd cycle (per patient) on [**2103-8-24**]. Since Friday
([**8-24**]), he noticed intermittent episodes of small amounts of
epistaxis from his left nostril which was followed by appearance
of petechiae on bilateral lower extremities involving inner
aspect of thigh and on shin. Labs in his rehab showed platelet
count of 1.  He was then transferred to ED.  In ED, his wbc was
found to be 0.6 and plt of 7.  He was admitted for observation.

ROS: Patient denies fevers, chills, chest pain, SOB, diarrhea,
constipation, hematochezia/melena, blurry vision, abdominal
pain, tingling numbness in extremities, dizziness.  He reports
malaise, early satiety. Rest of ROS unremarkable.

Past Medical History:
#HIV/AIDS--CD4-57/4%, VL [**Numeric Identifier 14614**] on [**2101-10-5**], not on meds since
then; Nadir CD4 57 prior to [**5-/2103**] admit, no documented thrush
or CMV in past
Prior treatment includes: LAM/ZDV/EFV, ?NFV;  TDF/FTC with FD
LPV/r (started [**2096-11-26**], stopped [**2096-12-19**] due to diarrhea but
restarted by [**1-3**], discontinued by [**7-/2097**]);  TDF/FTC and ATV/r
(started [**7-/2098**], self-discontinued [**12/2098**])
RPR non-reactive [**2099-5-5**].
Toxo IgG negative [**2097-6-11**].
HCV Ab negative [**2094-8-10**].
#pneumonia [**11/2096**] (Admitted [**Hospital1 112**]) thought to be viral
#History of anorectal HPV.  Last High resolution anoscopy
[**2099-6-30**], path with AIN I x 2.  Last anal pap done on that day.





Social History:
Patient lives alone.  Patient works with [**Hospital1 14615**], processing donations.
Tobacco:  1 ppd x 12 years, quit in [**2103-6-13**]
ETOH:  Heavy drinking in the past, quit in [**2103-6-13**]
Recreational drugs:  cocaine and marijuana years ago


Family History:
No family history of cancer, neurological issues, heart disease.

Physical Exam:
VS: Tc 98.1  HR: 82  BP: 104/56  RR: 16  02: 99% RA

GEN: pleasant, A&Ox3, NAD
HEENT: NCAT, PERRL, mildly injected conjunctivae b/l, EOMI,
sclerae anicteric, neck supple, MMM, poor dentition, no LAD
CV: RRR, normal S1, S2, no M/G/R
PULM: good air movement, no wheezes, no rales
BACK: no focal tenderness, no CVAT, has a small healing ulcer in
coccyx measuring 0.5 x 0.5 cm.
GI: normoactive BS, soft, non-tender, non-distended, no HSP
MSK: no joint swelling or erythema
EXT: warm and well perfused, no edema, 2+ DP pulses palpable
bilaterally, small area of skin breakdown on R knee
LYMPH: no cervical, axillary LAD;
SKIN: no rashes, no jaundice. + petechiae on b/l LE on inner
aspect of thigh and over the shin
NEURO: AAOx3, 4/5 strength in bil UE, [**5-17**] in RLE, [**4-17**] in L LE;
CN
intact.


Pertinent Results:
[**2103-8-26**] 07:20PM URINE  COLOR-Straw APPEAR-Clear SP [**Last Name (un) 155**]-1.005
[**2103-8-26**] 07:20PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0
LEUK-NEG
[**2103-8-26**] 05:50PM   LACTATE-1.2
[**2103-8-26**] 05:42PM   GLUCOSE-100 UREA N-21* CREAT-0.4* SODIUM-133
POTASSIUM-3.7 CHLORIDE-100 TOTAL CO2-27 ANION GAP-10
[**2103-8-26**] 05:42PM   WBC-0.6*# RBC-2.63* HGB-7.8* HCT-21.9* MCV-83
MCH-29.6 MCHC-35.6* RDW-16.2*
[**2103-8-26**] 05:42PM   NEUTS-68.2 LYMPHS-28.3 MONOS-0.3* EOS-1.7
BASOS-1.5
[**2103-8-26**] 05:42PM   PLT COUNT-7*#
[**2103-8-26**] 05:42PM   PT-14.3* PTT-29.8 INR(PT)-1.2*
[**2103-8-25**] 06:18AM   ALT(SGPT)-22 AST(SGOT)-11 LD(LDH)-168 ALK
PHOS-71 TOT BILI-0.9
[**2103-8-25**] 06:18AM   ALBUMIN-2.2* CALCIUM-7.3* PHOSPHATE-2.9
MAGNESIUM-2.0 URIC ACID-2.2*
[**2103-8-25**] 06:18AM   HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-1+
MACROCYT-OCCASIONAL MICROCYT-OCCASIONAL POLYCHROM-NORMAL
TARGET-1+ BURR-OCCASIONAL
[**2103-8-25**] 06:18AM   FIBRINOGE-158
.
[**2103-8-18**] Chest X Ray: No evidence for active cardiopulmonary
disease.
.
[**2103-8-7**] CT chest:
1. Dramatic interval improvement in multiple bilateral
ground-glass opacities with minimal if any residual opacities
remaining.
2. Moderate bilateral effusions with associated atelectasis are
non-hemorrhagic.
3. Splenomegaly.
.
[**2103-7-19**]: MR head: Prominence of ventricles and sulci consistent
with global
cerebral atrophy given the history of HIV/AIDS. Few T2 and FLAIR

hyperintensities in the subcortical and periventricular white
matter
consistent with chronic small vessel ischemic disease.
.
[**2103-7-11**] BM biopsy: DIFFUSE INVOLVEMENT BY NON-HODGKIN'S LYMPHOMA
(DIFFUSE LARGE B-CELL LYMPHOMA).

[**2103-9-6**] 7:42 am [**Month/Day/Year **]      Source: Induced.

                            **FINAL REPORT [**2103-9-21**]**

   GRAM STAIN (Final [**2103-9-6**]):
      [**11-6**] PMNs and >10 epithelial cells/100X field.
      Gram stain indicates extensive contamination with upper
respiratory
      secretions. Bacterial culture results are invalid.
      PLEASE SUBMIT ANOTHER SPECIMEN.

   RESPIRATORY CULTURE (Final [**2103-9-6**]):
      TEST CANCELLED, PATIENT CREDITED.

   Immunoflourescent test for Pneumocystis jirovecii (carinii)
(Final
      [**2103-9-6**]):
      SPECIMEN NOT PROCESSED DUE TO: QUANTITY NOT SUFFICIENT.
      Less than 2 ml received.
      Reported to and read back by [**First Name8 (NamePattern2) 5557**] [**Last Name (NamePattern1) **] RN @1005,
[**2103-9-6**].
      TEST CANCELLED, PATIENT CREDITED.

   FUNGAL CULTURE (Final [**2103-9-21**]):
      GRAM STAIN OF THIS SPECIMEN INDICATES CONTAMINATION WITH
      OROPHARYNGEAL SECRETIONS AND INVALIDATES RESULTS.
      Specimen is only screened for Cryptococcus species. New
specimen is
      recommended.
[**2103-9-16**] 4:57 pm BRONCHOALVEOLAR LAVAGE

   GRAM STAIN (Final [**2103-9-16**]):
      2+   (1-5 per 1000X FIELD):   POLYMORPHONUCLEAR
LEUKOCYTES.
      2+   (1-5 per 1000X FIELD):   GRAM POSITIVE COCCI.
                                    IN PAIRS AND CLUSTERS.

   RESPIRATORY CULTURE (Final [**2103-9-18**]):
      >100,000 ORGANISMS/ML. Commensal Respiratory Flora.

   Immunoflourescent test for Pneumocystis jirovecii (carinii)
(Final
      [**2103-9-17**]):    NEGATIVE for Pneumocystis jirovecii
(carinii)..

   FUNGAL CULTURE (Final [**2103-10-1**]):
      [**Female First Name (un) **] ALBICANS, PRESUMPTIVE IDENTIFICATION.

   ACID FAST CULTURE (Preliminary):    NO MYCOBACTERIA ISOLATED.


   ACID FAST SMEAR (Final [**2103-9-18**]):
      NO ACID FAST BACILLI SEEN ON DIRECT SMEAR.
      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR.
[**2103-9-29**] 12:30 am IMMUNOLOGY      Source: Line-picc.

                            **FINAL REPORT [**2103-10-1**]**

   HIV-1 Viral Load/Ultrasensitive (Final [**2103-10-1**]):
      HIV-1 RNA is not detected.
[**2103-10-4**] 10:15 am BLOOD CULTURE      Source: Line-PICC.

                            **FINAL REPORT [**2103-10-7**]**

   Blood Culture, Routine (Final [**2103-10-7**]):
      ENTEROCOCCUS FAECIUM.    FINAL SENSITIVITIES.
         Daptomycin MIC = 1.5 MCG/ML.
         Daptomycin Sensitivity testing performed by Etest.
         HIGH LEVEL STREPTOMYCIN SCREEN: Susceptible to
1000mcg/ml of
         streptomycin.  Screen predicts possible synergy with
selected
         penicillins or vancomycin.  Consult ID for details..
         HIGH LEVEL GENTAMICIN SCREEN: Susceptible to 500 mcg/ml
of
         gentamicin. Screen predicts possible synergy with
selected
         penicillins or vancomycin. Consult ID for details.

                              SENSITIVITIES: MIC expressed in
MCG/ML

_________________________________________________________
                             ENTEROCOCCUS FAECIUM
                             |
AMPICILLIN------------  